Cannabis-based sleep aid prompts new questions about dependence

A cannabis-derived ingredient sold in sleep products showed signs of tolerance and physical dependence in an animal study. The results raise fresh questions about what repeated use of cannabinol, or CBN, might do, even though its effects at typical consumer doses are still not well understood.

CBN is one of the many compounds found in cannabis. It is often discussed apart from THC, the main ingredient associated with cannabis intoxication, although the two may overlap in some of their effects under certain conditions.

Researchers at the University of Connecticut gave mice CBN twice a day for three days. With repeated exposure, the animals became less sensitive to some of the drug’s effects, which scientists describe as tolerance.

Tolerance means that the same dose has less impact than it did at first. By itself, it does not prove addiction, since addiction involves behavioral patterns that this animal study was not designed to assess.

The researchers also observed physical signs that resembled withdrawal, including twitching and paw movements. Those findings indicate the animals adapted to repeated exposure, but they do not allow researchers to predict how a person might feel after stopping a CBN product.

In another experiment, the team used mice trained to react when they detected THC-like effects. Some of those mice responded to CBN in a similar way, suggesting that the two drugs produced overlapping internal cues in that test.

The study, published in Drug and Alcohol Dependence, did not examine whether CBN helps insomnia. Instead, it focused on how the nervous system responds to the compound, which is a different question from whether someone falls asleep faster or wakes feeling more rested.

Dosage, delivery method, and duration of use all matter when comparing animal research with consumer products. Human studies would need to test preparations people actually use and separate CBN’s effects from those of other ingredients in the same product.

The research also highlights why scientists need to study what happens after people stop using a sleep product, not just while they are taking it. A trial that ends with the last dose could miss effects that only appear afterward.

The brief experiment also leaves unanswered how responses might change after weeks or months of use.

Overall, the findings give researchers specific safety questions to carry into human studies. The next step is to determine whether repeated use at realistic doses alters people’s responses over time, and whether any such changes occur alongside a measurable benefit for sleep.

If you are interested in this topic, please read articles about Diet can have a big impact on sleep quality, and Evening coffee may change brain’s sleep more than you realize.

For more information, please see articles about Refined carbs linked to insomnia risk in women, and How your sleep schedule can boost your mood.

Source: University of Connecticut.